Skip to main content
Log in

Novel benzoxazole derivatives featuring rhodanine and analogs as antihypergycemic agents: synthesis, molecular docking, and biological studies

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A novel series of benzoxazolyl linked benzylidene based rhodanine and their cyclic analogs were synthesized, characterized and evaluated for their α-amyloglucosidase inhibitory activity. Out of eight target compounds, two compounds (4b and 5b) displayed potent inhibitory activity against α-amyloglucosidase with IC50 values in the range of 0.24 ± 0.01–0.94 ± 0.01 µM as compared to standard drug acarbose. Among all the tested compounds, compound 5b containing rhodanine at 3-position of phenyl was found to be the most active inhibitor of α-amyloglucosidase. Docking studies showed the existence of potential H-bonding interactions between synthesized compounds and α-glucosidase which might be responsible for good biological activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ertan-Bolelli T, Yildiz I, Ozgen-Ozgacar S (2016) Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives. Med Chem Res 25:553–567

    Article  CAS  Google Scholar 

  • Ghani U (2015) Re-exploring promising alpha-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in haystack. Eur J Med Chem 103:133–162

    Article  CAS  PubMed  Google Scholar 

  • Gray GM (1975) Carbohydrates digestion and absorption-role of small intestine. N Eng J Med 292:1225–1230

    Article  CAS  Google Scholar 

  • Kasabri V, Afifi FU, Hamdan I (2011) In vitro and in vivo acute antihypergycemic effects of five selected indigenous plants from Jordan used in tradiational medicine. J Ethpharm 133:888–896

    Article  Google Scholar 

  • Lazer ES, Miao CK, Wong HC, Sorcek R, Spero DM, Gilman A, Pal K, Behnke M, Graham AG, Watrous JM, Homon CA, Nagel J, Shah A, Guindon Y, Farina PR, Adams J (1994) Benzoxazolamines and benzthiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action. J Med Chem 37:913–923

    Article  CAS  PubMed  Google Scholar 

  • Notkins AL (2002) Immunologic and genetic factors in type 1 diabetes. J Biol Chem 277:43545–43548

    Article  CAS  PubMed  Google Scholar 

  • Rida SM, Ashour FA, El-Hawash SAM, ElSemary MM, Badr MH, Shalaby MA (2005) Synthesis of some novel benzoxazole derivatives as anticancer anti-HIV-1 and antimicrobial agents. Eur J Med Chem 40:949–959

    Article  CAS  PubMed  Google Scholar 

  • Seth K, Garg SK, Kumar R, Purohit P, Meena VS, Goyal R, Banergee UC, Chakraborti AK (2014) 2-(2-Arylphenyl)benzoxazole as a novel anti-inflammatory scaffold: synthesis and biological evaluation. Med Chem Lett 5:512–516

    Article  CAS  Google Scholar 

  • Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14

    Article  CAS  PubMed  Google Scholar 

  • Singh A, Verma RK, Kuhad A, Mall R (2017) Novel indol-2-carboxalic acid linked 3-phenyl-2-alkoxy propanoic acids: Synthesis, molecular docking and in vivo antidiabetic studies. Med Chem Res 26:745–759

    Article  CAS  Google Scholar 

  • Sybyl 7. 3 (2006) Tripose Inc. 1699 Hanley Road, St. Louis63144, USA

  • Tipparaju SK, Joyasawal S, Pieroni M, Kaiser M, Brun R, Kozikowski AP (2008) In Prursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxy pyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery of N-(2-Benzoxazole-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes. J Med Chem 51:7344–7347

    Article  CAS  PubMed  Google Scholar 

  • Verma RK, Ghosh P, Kumar V, Wadhwa LK (2012a) The application of comparative molecular field analysis for the design of α–anilino substituted-3-phenyl propanoic acids as novel PPARα/γ dual ligands. Med Chem Res 21:2873–2884

    Article  CAS  Google Scholar 

  • Verma RK, Ghosh P, Kumar V, Wadhwa LK (2013a) Design, synthesis and computational validation of novel benzimidazole/indole-based PPARα and PPARγ partial agonists. J Chem Sci 125:1555–1571

    Article  CAS  Google Scholar 

  • Verma RK, Kumar V, Ghosh P, Wadhwa LK (2012b) Heterocyclyl linked anilines and benzaldehydes as precursors for biologically significant new chemical entities. J Chem Sci 124:1063–1069

    Article  CAS  Google Scholar 

  • Verma RK, Kumar V, Ghosh P, Wadhwa LK (2013b) 3D-QSAR study of tyrosine and propanoic acid derivatives as PPARα/γ dual agonists using CoMSIA. Med Chem Res 22:287–302

    Article  CAS  Google Scholar 

  • Verma RK, Mall R, Ghosh P, Kumar V (2013c) Design and synthesis of benzimidazole-linked meta-substituted benzylidenes/benzyls as biologically significant new chemical entities. Synth Commun 43:1882–1895

    Article  CAS  Google Scholar 

  • Verma RK, Mall R, Singh A (2015) Indole Linked meta-subsituted benzylidene-based novel PPAR ligands: synthetic and docking studies. Med Chem Res 24:1396–1407

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors are thankful to the Punjabi University, Patiala authorities for providing the necessary research facilities. We are also grateful to Director and Mr. Avtar Singh of Sophisticated Analytical Instrumentation Facility (SAIF), Panjab University, Chandigarh, respectively, for extending the facilities for spectral analysis of the compounds reported in this paper. One of the authors, Mr. Varinder Singh, is thankful to UGC for providing Maulana Azad National fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajiv Mall.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, V., Singh, A., Singh, G. et al. Novel benzoxazole derivatives featuring rhodanine and analogs as antihypergycemic agents: synthesis, molecular docking, and biological studies. Med Chem Res 27, 735–743 (2018). https://doi.org/10.1007/s00044-017-2097-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-017-2097-1

Keywords

Navigation